Prevalence of TT virus in Japanese patients with fulminant hepatic failure.

被引:0
|
作者
Tanaka, M
Nishiguchi, S
Enomoto, M
Tanaka, T
Minamitani, S
Fukuda, K
Habu, D
Takeda, T
Shiomi, S
Seki, S
Kuroki, T
Yano, Y
Otani, S
机构
[1] Osaka City Univ, Sch Med, Dept Biochem 2, Osaka 545, Japan
[2] Osaka City Univ, Sch Med, Dept Internal Med 3, Osaka 545, Japan
[3] Osaka City Univ, Sch Med, Dept Publ Hlth, Osaka 545, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
515
引用
收藏
页码:291A / 291A
页数:1
相关论文
共 50 条
  • [21] TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis
    Charlton, M
    Adjei, P
    Poterucha, J
    Zein, N
    Moore, B
    Therneau, T
    Krom, R
    Wiesner, R
    HEPATOLOGY, 1998, 28 (03) : 839 - 842
  • [22] Fulminant hepatic failure. Unusual cardiac failure presentation.
    Ridruejo, E
    Laurini, J
    Cingolani, O
    MEDICINA-BUENOS AIRES, 2000, 60 (04) : 491 - 494
  • [23] Successful portal vein arterialization for fulminant hepatic failure.
    Nardo, B
    Montalti, R
    Beltempo, P
    Bertelli, R
    Puviani, L
    Caraceni, P
    Bernardi, M
    Rossi, C
    Martinelli, G
    Cavallari, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 215 - 215
  • [24] Identification of oval cells in human fulminant hepatic failure.
    Davies, R
    Olynyk, JK
    Angus, P
    Yeoh, G
    HEPATOLOGY, 2002, 36 (04) : 169A - 169A
  • [25] Experience with plasmapheresis and liver transplantation for fulminant hepatic failure.
    Murakami, T
    Fahmy, A
    John, DG
    Morgan, GR
    Diflo, T
    Tobias, H
    Eperman, LW
    LIVER TRANSPLANTATION, 2006, 12 (05) : C93 - C93
  • [26] Comparison of the applicability: Of two prognostic indicator scores in patients with fulminant hepatic failure.
    Choi, WC
    Arnaout, WS
    Villamil, FG
    Demetriou, AA
    Vierling, JM
    GASTROENTEROLOGY, 2000, 118 (04) : A896 - A896
  • [27] Hodgkin's lymphoma presenting as fulminant hepatic failure.
    Cohen, LB
    Imrie, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1246 - A1246
  • [28] Analysis of the phase I trial of ELAD in the management of patients with fulminant hepatic failure.
    Millis, JM
    O'Grady, J
    Heffron, T
    Kramer, D
    Hart, M
    Caldwell, S
    Conlin, C
    HEPATOLOGY, 2004, 40 (04) : 506A - 507A
  • [29] Circulating level of neuropeptides (CGRP, VIP,NPY) in patients with fulminant hepatic failure.
    Strauss, GI
    Edvinsson, L
    Larsen, P
    Moeller, K
    Knudsen, GM
    HEPATOLOGY, 2000, 32 (04) : 398A - 398A
  • [30] Cerebral glutamine efflux exceeds ammonia influx in patients with fulminant hepatic failure.
    Strauss, GI
    Larsen, FS
    Knudsen, GM
    Kondrup, J
    HEPATOLOGY, 2000, 32 (04) : 397A - 397A